Position in PCVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,009,145
+$529,784 QoQ
Shares Held
34,563
+35.8% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#137
of 329 holders
Holding Since
Sep 2022
15 quarters on record
Voting authority
Sole 82%
Shared 0%
None 18%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $5,647,082,401 across 216 Biotechnology names. PCVX ranks #122 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,126,080 | $702,155,918 | |
| 2 | INCY |
Incyte Corp
|
5,320,901 | $603,177,333 | |
| 3 | EXEL |
Exelixis, Inc.
|
11,023,943 | $599,812,735 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,522,568 | $366,893,205 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
5,699,541 | $326,127,732 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
616,170 | $306,070,117 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,295,450 | $242,611,869 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,305,412 | $241,404,446 |
All Filings in PCVX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,009,145 | 34,563 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $1,479,361 | 25,458 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $681,116 | 14,762 | Shares | Other | 2026-02-17 | |
| 2025-06-30 | $207,445 | 6,381 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $248,157 | 6,572 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,006,879 | 24,516 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $1,269,882 | 11,113 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $820,038 | 10,860 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $719,440 | 10,532 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $759,880 | 12,100 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $637,250 | 12,500 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $717,637 | 14,370 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $477,607 | 12,743 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $548,404 | 11,437 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $223,824 | 9,326 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||